MannKind | MNKD - 現金と同等





現金と同等 変化する 日付
Adma Biologics USD 87.63M 26.24M 2025-12
BioCryst Pharmaceuticals USD 335.91M 251.83M 2025-12
Eli Lilly USD 7.27B 2.52B 2025-12
Halozyme Therapeutics USD 133.82M 285.84M 2025-12
Insmed USD 510.44M 175.68M 2025-12
Karyopharm Therapeutics USD 37.67M 1.05M 2025-09
MacroGenics USD 57.22M 22.91M 2025-12
MannKind USD 74.88M 52.51M 2025-12
Merck USD 18.17B 10.16B 2025-09
Minerva Neurosciences USD 82.3M 70.02M 2025-12
Novavax USD 240.63M 27.39M 2025-12
Novo Nordisk DKK 38.94B 24.15B 2025-03
Pfizer USD 1.34B 295M 2025-09
Sanofi EUR 7.66B 1.25B 2025-12
Xencor USD 54.07M 25.78M 2025-12